Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) Infectious Disease Diagnostics Market Growth
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease. The U.S. FDA (United States Food and Drug Administration) is responsible for overseeing all activities related to the marketing of diagnostic products. POC diagnosis is cost-efficient and time saving, as well as offer various benefits such as can be performed easily, prevent sample spillage, no necessity of skilled professionals, etc. Market Dynamics: The emergence of COVID-19 (SARS-CoV-2) is expected to propel the growth of the point-of-care (POC) infectious disease diagnostics market. For instance, in February 2021, RNA Disease Diagnostics secured an exclusive global license to a cutting-edge sensor technology joi...